Literature DB >> 21921082

Microbial pathogenesis of bacterial biofilms: a causative factor of vascular surgical site infection.

Elisabeth Frei1, Kelley Hodgkiss-Harlow, Peter J Rossi, Charles E Edmiston, Dennis F Bandyk.   

Abstract

Vascular surgical site infection (SSI) is caused by pathogenic bacterial strains whose preferred mode of growth is within a surface biofilm. Bacterial biofilm formation can develop within hours to days in a wound and produces a recalcitrant infectious process especially in the presence of a prosthetic graft. The initial steps of biofilm formation are bacterial adhesion to biologic or inert surgical site structures followed by organism production of exopolysaccaride matrix which encases developing bacteria colonies to produce a protective microenvironment. As the biofilm matures, a dynamic process of organism cell-to-cell signaling occurs with varying growth modes of sessile bacteria within the biofilm and the release of planktonic bacteria with the potential to spread and expand the biofilm-mediated infection. The prevalence of staphyloccocal strains causing vascular SSI is best understood when viewed as a biofilm-mediated infection with virulence factors related to specific cell surface adhesion proteins and bacteria-derived matrix production. Nonhealing surgical sites following lower limb revascularization, the late appearance of prosthetic graft infection caused by Staphylococcus epidermidis, and the development of groin site tracts after aortofemoral bypass grafting are clinical examples of a biofilm-mediated SSI. A mature biofilm within a wound or coating a prosthetic device exhibits resistance to host defenses and selected antibiotics, impairs wound healing, and is a perpetual irritant to that host by inciting a chronic inflammatory process. By understanding the microbial pathogenesis of biofilm formation, strategies to treat and prevent biofilm-mediated infection can be developed and utilized to reduce vascular SSIs.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21921082     DOI: 10.1177/1538574411419528

Source DB:  PubMed          Journal:  Vasc Endovascular Surg        ISSN: 1538-5744            Impact factor:   1.089


  8 in total

Review 1.  [Locoregional solutions for groin defects : Coverage after vascular surgery].

Authors:  M Cerny; Y Harder; A Zimmermann; H-H Eckstein; H-G Machens; J-T Schantz; T L Schenck
Journal:  Chirurg       Date:  2017-01       Impact factor: 0.955

2.  Identification of genes upregulated by the transcription factor Bcr1 that are involved in impermeability, impenetrability, and drug resistance of Candida albicans a/α biofilms.

Authors:  Thyagarajan Srikantha; Karla J Daniels; Claude Pujol; Elena Kim; David R Soll
Journal:  Eukaryot Cell       Date:  2013-04-05

3.  Activities of Combinations of Antistaphylococcal Antibiotics with Fusidic Acid against Staphylococcal Biofilms in In Vitro Static and Dynamic Models.

Authors:  Wafi Siala; Hector Rodriguez-Villalobos; Prabhavathi Fernandes; Paul M Tulkens; Françoise Van Bambeke
Journal:  Antimicrob Agents Chemother       Date:  2018-06-26       Impact factor: 5.191

4.  Diagnosis and Treatment of Vascular Surgery Related Infection.

Authors:  Yong-Gan Zhang; Xue-Li Guo; Yan Song; Chao-Feng Miao; Chuang Zhang; Ning-Heng Chen
Journal:  Open Biomed Eng J       Date:  2015-09-17

Review 5.  Groin Surgical Site Infection in Vascular Surgery: Systemic Review on Peri-Operative Antibiotic Prophylaxis.

Authors:  Bruno Amato; Rita Compagna; Salvatore De Vivo; Aldo Rocca; Francesca Carbone; Maurizio Gentile; Roberto Cirocchi; Francesco Squizzato; Andrea Spertino; Piero Battocchio
Journal:  Antibiotics (Basel)       Date:  2022-01-20

6.  In vitro determination of the antibiotic susceptibility of biofilm-forming Pseudomonas aeruginosa and Staphylococcus aureus: possible role of proteolytic activity and membrane lipopolysaccharide.

Authors:  Majed M Masadeh; Nizar M Mhaidat; Karem H Alzoubi; Emad I Hussein; Esra'a I Al-Trad
Journal:  Infect Drug Resist       Date:  2013-03-06       Impact factor: 4.003

7.  207-nm UV light - a promising tool for safe low-cost reduction of surgical site infections. I: in vitro studies.

Authors:  Manuela Buonanno; Gerhard Randers-Pehrson; Alan W Bigelow; Sheetal Trivedi; Franklin D Lowy; Henry M Spotnitz; Scott M Hammer; David J Brenner
Journal:  PLoS One       Date:  2013-10-16       Impact factor: 3.240

8.  Open wounds and rifampicin therapy are associated with rifampicin resistance among staphylococcal vascular graft/endograft infections.

Authors:  Yau Kei Stefan Leung; Bruno Ledergerber; Nadia Eberhard; Carlos A Mestres; Zoran Rancic; Alexander Zimmermann; Reinhard Zbinden; Silvio D Brugger; Annelies S Zinkernagel; Barbara Hasse
Journal:  JAC Antimicrob Resist       Date:  2021-03-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.